178 related articles for article (PubMed ID: 20389105)
21. V2R mutations and nephrogenic diabetes insipidus.
Bichet DG
Prog Mol Biol Transl Sci; 2009; 89():15-29. PubMed ID: 20374732
[TBL] [Abstract][Full Text] [Related]
22. A case of a novel mutant vasopressin receptor-dependent nephrogenic diabetes insipidus with bilateral non-obstructive hydronephrosis in a middle aged man: differentiation from aquaporin-dependent nephrogenic diabetes insipidus by response of factor VII and von Willebrand factor to 1-diamino-8-arginine vasopressin administration.
Miyakoshi M; Kamoi K; Uchida S; Sasaki S
Endocr J; 2003 Dec; 50(6):809-14. PubMed ID: 14709855
[TBL] [Abstract][Full Text] [Related]
23. Vasopressin receptor mutations causing nephrogenic diabetes insipidus.
Bichet DG; Turner M; Morin D
Proc Assoc Am Physicians; 1998; 110(5):387-94. PubMed ID: 9756088
[TBL] [Abstract][Full Text] [Related]
24. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance.
Spanakis E; Milord E; Gragnoli C
J Cell Physiol; 2008 Dec; 217(3):605-17. PubMed ID: 18726898
[TBL] [Abstract][Full Text] [Related]
25. Clinical phenotype of nephrogenic diabetes insipidus in females heterozygous for a vasopressin type 2 receptor mutation.
van Lieburg AF; Verdijk MA; Schoute F; Ligtenberg MJ; van Oost BA; Waldhauser F; Dobner M; Monnens LA; Knoers NV
Hum Genet; 1995 Jul; 96(1):70-8. PubMed ID: 7607658
[TBL] [Abstract][Full Text] [Related]
26. A novel AVPR2 missense mutation in an Asian family with inherited nephrogenic diabetes insipidus: A case report.
Zhang M; Yu Q; Chen C; Han J; Cheng B; Tian D
Medicine (Baltimore); 2019 Apr; 98(17):e15348. PubMed ID: 31027113
[TBL] [Abstract][Full Text] [Related]
27. Contiguous 22.1-kb deletion embracing AVPR2 and ARHGAP4 genes at novel breakpoints leads to nephrogenic diabetes insipidus in a Chinese pedigree.
Bai Y; Chen Y; Kong X
BMC Nephrol; 2018 Feb; 19(1):26. PubMed ID: 29394883
[TBL] [Abstract][Full Text] [Related]
28. Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with
Ikegawa K; Hachiya R; Akiba K; Hasegawa Y
Clin Pediatr Endocrinol; 2022; 31(2):87-92. PubMed ID: 35431445
[TBL] [Abstract][Full Text] [Related]
29. Nephrogenic diabetes insipidus.
Bichet DG
Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
[TBL] [Abstract][Full Text] [Related]
30. Functional characterization of the molecular defects causing nephrogenic diabetes insipidus in eight families.
Pasel K; Schulz A; Timmermann K; Linnemann K; Hoeltzenbein M; Jääskeläinen J; Grüters A; Filler G; Schöneberg T
J Clin Endocrinol Metab; 2000 Apr; 85(4):1703-10. PubMed ID: 10770218
[TBL] [Abstract][Full Text] [Related]
31. A large deletion of the AVPR2 gene causing severe nephrogenic diabetes insipidus in a Turkish family.
Saglar E; Deniz F; Erdem B; Karaduman T; Yönem A; Cagiltay E; Mergen H
Endocrine; 2014 May; 46(1):148-53. PubMed ID: 24026507
[TBL] [Abstract][Full Text] [Related]
32. A Novel Missense Mutation of Arginine Vasopressin Receptor 2 in a Chinese Family with Congenital Nephrogenic Diabetes Insipidus: X-Chromosome Inactivation in Female CNDI Patients with Heterozygote 814A>G Mutation.
Zang L; Gong Y; Li Y; Dou J; Lyu Z; Su X; Zhang Y; Mu Y
Biomed Res Int; 2022; 2022():7073158. PubMed ID: 35865667
[TBL] [Abstract][Full Text] [Related]
33. A female with X-linked Nephrogenic diabetes insipidus in a family with inherited central diabetes Insipidus: Case report and review of the literature.
Ding C; Beetz R; Rittner G; Bartsch O
Am J Med Genet A; 2020 May; 182(5):1032-1040. PubMed ID: 32073219
[TBL] [Abstract][Full Text] [Related]
34. Identification of mutations in the arginine vasopressin receptor 2 gene causing nephrogenic diabetes insipidus in Chinese patients.
Chen CH; Chen WY; Liu HL; Liu TT; Tsou AP; Lin CY; Chao T; Qi Y; Hsiao KJ
J Hum Genet; 2002; 47(2):66-73. PubMed ID: 11916004
[TBL] [Abstract][Full Text] [Related]
35. Novel AVPR2 mutations and clinical characteristics in 28 Chinese families with congenital nephrogenic diabetes insipidus.
Li Q; Tian D; Cen J; Duan L; Xia W
J Endocrinol Invest; 2021 Dec; 44(12):2777-2783. PubMed ID: 34101133
[TBL] [Abstract][Full Text] [Related]
36. Novel and recurrent variants in AVPR2 in 19 families with X-linked congenital nephrogenic diabetes insipidus.
Joshi S; Kvistgaard H; Kamperis K; Færch M; Hagstrøm S; Gregersen N; Rittig S; Christensen JH
Eur J Pediatr; 2018 Sep; 177(9):1399-1405. PubMed ID: 29594432
[TBL] [Abstract][Full Text] [Related]
37. AQP2: Mutations Associated with Congenital Nephrogenic Diabetes Insipidus and Regulation by Post-Translational Modifications and Protein-Protein Interactions.
Gao C; Higgins PJ; Zhang W
Cells; 2020 Sep; 9(10):. PubMed ID: 32993088
[TBL] [Abstract][Full Text] [Related]
38. [Identification of mutations in the arginine vasopressin receptor 2 gene in congenital nephrogenic diabetes insipidus patients].
Gu F; Shi Y; Deng J; Jin Z
Zhonghua Yi Xue Za Zhi; 2002 Oct; 82(20):1401-5. PubMed ID: 12509923
[TBL] [Abstract][Full Text] [Related]
39. Functional characterization of novel loss-of-function mutations in the vasopressin type 2 receptor gene causing nephrogenic diabetes insipidus.
Böselt I; Tramma D; Kalamitsou S; Niemeyer T; Nykänen P; Gräf KJ; Krude H; Marenzi KS; Di Candia S; Schöneberg T; Schulz A
Nephrol Dial Transplant; 2012 Apr; 27(4):1521-8. PubMed ID: 21917732
[TBL] [Abstract][Full Text] [Related]
40. Molecular genetic study of congenital nephrogenic diabetes insipidus and rescue of mutant vasopressin V2 receptor by chemical chaperones.
Cheong HI; Cho HY; Park HW; Ha IS; Choi Y
Nephrology (Carlton); 2007 Apr; 12(2):113-7. PubMed ID: 17371330
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
